EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE‐CVD Study)

Dhanunjaya Lakkireddy, Dominick J Angiolillo, Kristofer Charlton-Ouw, Brian Jefferson, Syed Peeran, Mohannad Bisharat, Luis Ortega-Paz, Ante Harxhi, Simrati Kaul, Evelyne Michaud, Stephanie Juan, Breeana Woods und 3 weitere

Clinical Cardiology · 2024

DOI: 10.1002/clc.70039 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Dhanunjaya Lakkireddy und 14 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City Heart Rhythm Institute, HCA Midwest Health, Overland Park, Kansas, USA. Hauptthemen laut MEDLINE: Coronary Artery Disease, Peripheral Arterial Disease, Mobile Applications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by Janssen Scientific Affairs, LLC..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Coronary artery disease (CAD) and peripheral artery disease (PAD) increase the risks of cardiovascular events and death. Digital health technologies are rapidly expanding to improve healthcare quality and access. The Care4Today Connect (C4T CAD‐PAD) mobile application is designed to help patients with CAD and/or PAD improve medication adherence, learn about their disease, make lifestyle modifications, and enhance healthcare provider (HCP) connection via an HCP‐facing portal. Hypothesis & Methods The prospective, single‐arm, multicenter, noninterventional iPACE‐CVD (innovative Patient compAnion impaCting health outcomEs: a CardioVascular Digital health program) study ( ClinicalTrials.gov identifier: NCT06052319) is evaluating engagement and usefulness of the application for patients with CAD and/or PAD in clinical settings. Application access is provided with a code from patients' HCPs. Key features include medication and health experience tracking. The application is available in English and Spanish and for iOS and Android devices. Engagement is defined as the proportion of patients who use the application for ≥ 10 weeks during the 3‐month study period. Application use is defined as the number of patients using ≥ 1 application feature(s) each week. Usefulness is determined by the percentage of engaged patients who complete the My Feedback Matters survey with a satisfaction response score of > 2 (on a 5‐point scale, where 1 = strongly disagree and 5 = strongly agree ) for at least three of the six questions.

Results

A total of 271 participants were enrolled between November 29, 2023, and May 15, 2024. The study concluded on August 15, 2024.

Conclusion

This study will help enhance the application for subsequent studies. Trial Registration: NCT06052319

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePeripheral Arterial DiseaseMobile ApplicationsHumansProspective StudiesFemaleMaleDisease ManagementTelemedicineMiddle AgedAgedMedication AdherenceDigital Health

Stichwörter der Autor:innen

cardiovascular diseasehealth trackermedication adherencemobile health (mHealth)patient educationpatient engagementsmartphone application

Autor:innen und Institutionen

  • Kansas City Heart Rhythm Institute, HCA Midwest Health, Overland Park, Kansas, USA.
  • Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA.
  • Department of Clinical Sciences, University of Houston College of Medicine, Houston, Texas, USA.
  • Tristar Centennial Medical Center, Nashville, Tennessee, USA.
  • Coastal Cardiothoracic and Vascular Surgery, Portsmouth Regional Hospital, Portsmouth, New Hampshire, USA.
  • Ashchi Heart and Vascular Center and HCA Florida Memorial Hospital, Jacksonville, Florida, USA.

Förderung

  • This study was supported by Janssen Scientific Affairs, LLC.

Zitieren

APA

Lakkireddy, D., Angiolillo, D. J., Charlton-Ouw, K., Jefferson, B., Peeran, S., Bisharat, M., Ortega-Paz, L., Harxhi, A., Kaul, S., Michaud, E., Juan, S., Woods, B., Damaraju, C. V., Fontana, G., & Bonaca, M. P. (2024). Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE‐CVD Study). Clinical Cardiology. https://doi.org/10.1002/clc.70039

Vancouver

Lakkireddy D, Angiolillo DJ, Charlton-Ouw K, Jefferson B, Peeran S, Bisharat M, et al. Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE‐CVD Study). Clinical Cardiology. 2024. doi:10.1002/clc.70039

BibTeX
@article{Lakkireddy2024,
  author = {Lakkireddy, Dhanunjaya and Angiolillo, Dominick J and Charlton-Ouw, Kristofer and Jefferson, Brian and Peeran, Syed and Bisharat, Mohannad and Ortega-Paz, Luis and Harxhi, Ante and Kaul, Simrati and Michaud, Evelyne and Juan, Stephanie and Woods, Breeana and Damaraju, C V and Fontana, Gregory and Bonaca, Marc P},
  title = {Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE‐CVD Study)},
  journal = {Clinical Cardiology},
  year = {2024},
  doi = {10.1002/clc.70039}
}
Kostenlos starten →